VIRS
Pacer BioThreat Strategy ETF
VIRS
VIRS
Delisted
VIRS was delisted on the 10th of October, 2024.
4 hedge funds and large institutions have $1.12M invested in Pacer BioThreat Strategy ETF in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$317K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$104K |
Top Sellers
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$1.17M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$329K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Royal Bank of Canada
Toronto,
Ontario, Canada
| $346K | -$329K | -13,030 | -49% |
|
|
2
Osaic Holdings
Scottsdale,
Arizona
| $340K | -$1.17M | -46,451 | -77% |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $317K | +$317K | +12,597 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $116K | +$104K | +4,130 | +896% |
|